Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Para-aortic Lymphnodes Removal During Upfront Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoa: Should it be Performed? A Multicentre Randomized Controlled Trial.

NCT04571294 is registered in ClinicalTrials.gov with Humanitas Hospital, Italy as lead sponsor.

NCT NCT04571294
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04571294 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Para-aortic Lymphnodes Removal During Upfront Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoa: Should it be Performed? A Multicentre Randomized Controlled Trial.
Lead sponsor
Humanitas Hospital, Italy
Phase
Not applicable
Overall status
Recruiting
Start date
May 26, 2020
Completion date
May 31, 2025
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreas adenocarcinoma, pancreas cancer, pancreaticoduodenal lymphadenopathy